ID   SRMS_HUMAN              Reviewed;         488 AA.
AC   Q9H3Y6;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-APR-2017, entry version 138.
DE   RecName: Full=Tyrosine-protein kinase Srms;
DE            EC=2.7.10.2;
GN   Name=SRMS; Synonyms=C20orf148;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DOK1, N-TERMINAL
RP   REGION, PHOSPHORYLATION AT TYR-380, AND MUTAGENESIS OF TRP-223;
RP   LYS-258 AND TYR-380.
RX   PubMed=23822091; DOI=10.1111/febs.12420;
RA   Goel R.K., Miah S., Black K., Kalra N., Dai C., Lukong K.E.;
RT   "The unique N-terminal region of SRMS regulates enzymatic activity and
RT   phosphorylation of its novel substrate Dok1.";
RL   FEBS J. 280:4539-4559(2013).
RN   [3]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-73; ARG-75; VAL-88; LEU-301;
RP   GLU-377; VAL-397; LEU-452; THR-453; LEU-457 AND THR-465.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase which
CC       phosphorylates DOK1 on tyrosine residues. May be involved in
CC       proliferation or differentiation of keratinocytes in the skin.
CC       {ECO:0000269|PubMed:23822091}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Interacts (via the SH2 and SH3 domains) with DOK1.
CC       {ECO:0000269|PubMed:23822091}.
CC   -!- INTERACTION:
CC       Q99704:DOK1; NbExp=7; IntAct=EBI-8541270, EBI-1384360;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23822091}.
CC       Note=Localizes to punctate cytoplasmic structures.
CC   -!- TISSUE SPECIFICITY: Highly expressed in most breast cancers (at
CC       protein level).
CC   -!- DOMAIN: The N-terminal region regulates its kinase activity.
CC       {ECO:0000269|PubMed:23822091}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL121829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS13525.1; -.
DR   RefSeq; NP_543013.1; NM_080823.3.
DR   ProteinModelPortal; Q9H3Y6; -.
DR   SMR; Q9H3Y6; -.
DR   BioGrid; 112603; 3.
DR   IntAct; Q9H3Y6; 2.
DR   STRING; 9606.ENSP00000217188; -.
DR   BindingDB; Q9H3Y6; -.
DR   ChEMBL; CHEMBL5703; -.
DR   GuidetoPHARMACOLOGY; 2207; -.
DR   iPTMnet; Q9H3Y6; -.
DR   PhosphoSitePlus; Q9H3Y6; -.
DR   BioMuta; SRMS; -.
DR   DMDM; 27805732; -.
DR   EPD; Q9H3Y6; -.
DR   MaxQB; Q9H3Y6; -.
DR   PaxDb; Q9H3Y6; -.
DR   PeptideAtlas; Q9H3Y6; -.
DR   PRIDE; Q9H3Y6; -.
DR   DNASU; 6725; -.
DR   Ensembl; ENST00000217188; ENSP00000217188; ENSG00000125508.
DR   GeneID; 6725; -.
DR   KEGG; hsa:6725; -.
DR   UCSC; uc002yfi.3; human.
DR   CTD; 6725; -.
DR   DisGeNET; 6725; -.
DR   GeneCards; SRMS; -.
DR   HGNC; HGNC:11298; SRMS.
DR   HPA; CAB044668; -.
DR   HPA; CAB044669; -.
DR   HPA; HPA073987; -.
DR   neXtProt; NX_Q9H3Y6; -.
DR   OpenTargets; ENSG00000125508; -.
DR   PharmGKB; PA36122; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118938; -.
DR   HOGENOM; HOG000233858; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; Q9H3Y6; -.
DR   KO; K08895; -.
DR   OMA; LYEVFTY; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; Q9H3Y6; -.
DR   TreeFam; TF351634; -.
DR   Reactome; R-HSA-8849472; PTK6 Down-Regulation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; Q9H3Y6; -.
DR   GenomeRNAi; 6725; -.
DR   PRO; PR:Q9H3Y6; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000125508; -.
DR   CleanEx; HS_SRMS; -.
DR   Genevisible; Q9H3Y6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0009968; P:negative regulation of signal transduction; TAS:Reactome.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; SH2 domain;
KW   SH3 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    488       Tyrosine-protein kinase Srms.
FT                                /FTId=PRO_0000088160.
FT   DOMAIN       51    112       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      120    212       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      230    488       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     236    244       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1     51       N-terminal.
FT   ACT_SITE    350    350       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     258    258       ATP.
FT   MOD_RES     380    380       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:23822091}.
FT   VARIANT      73     73       R -> C (in dbSNP:rs56053583).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041831.
FT   VARIANT      75     75       G -> R (in dbSNP:rs55863722).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041832.
FT   VARIANT      88     88       I -> V (in dbSNP:rs35558836).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041833.
FT   VARIANT     218    218       P -> L (in dbSNP:rs378483).
FT                                /FTId=VAR_051700.
FT   VARIANT     255    255       V -> M (in dbSNP:rs34969822).
FT                                /FTId=VAR_051701.
FT   VARIANT     301    301       V -> L (in dbSNP:rs310657).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041834.
FT   VARIANT     325    325       P -> L (in dbSNP:rs8122355).
FT                                /FTId=VAR_051702.
FT   VARIANT     377    377       D -> E (in dbSNP:rs55838540).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041835.
FT   VARIANT     397    397       A -> V (in dbSNP:rs6011889).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041836.
FT   VARIANT     452    452       P -> L (in dbSNP:rs8120713).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041837.
FT   VARIANT     453    453       A -> T (in dbSNP:rs310655).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041838.
FT   VARIANT     457    457       V -> L (in dbSNP:rs310654).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041839.
FT   VARIANT     465    465       S -> T (in dbSNP:rs33933649).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041840.
FT   MUTAGEN     223    223       W->A: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:23822091}.
FT   MUTAGEN     258    258       K->M: Loss of kinase activity. Exhibits a
FT                                diffused cytoplasmic localization.
FT                                {ECO:0000269|PubMed:23822091}.
FT   MUTAGEN     380    380       Y->F: Significant reduction in
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:23822091}.
SQ   SEQUENCE   488 AA;  54507 MW;  83193AD26C5F6F68 CRC64;
     MEPFLRRRLA FLSFFWDKIW PAGGEPDHGT PGSLDPNTDP VPTLPAEPCS PFPQLFLALY
     DFTARCGGEL SVRRGDRLCA LEEGGGYIFA RRLSGQPSAG LVPITHVAKA SPETLSDQPW
     YFSGVSRTQA QQLLLSPPNE PGAFLIRPSE SSLGGYSLSV RAQAKVCHYR VSMAADGSLY
     LQKGRLFPGL EELLTYYKAN WKLIQNPLLQ PCMPQKAPRQ DVWERPHSEF ALGRKLGEGY
     FGEVWEGLWL GSLPVAIKVI KSANMKLTDL AKEIQTLKGL RHERLIRLHA VCSGGEPVYI
     VTELMRKGNL QAFLGTPEGR ALRLPPLLGF ACQVAEGMSY LEEQRVVHRD LAARNVLVDD
     GLACKVADFG LARLLKDDIY SPSSSSKIPV KWTAPEAANY RVFSQKSDVW SFGVLLHEVF
     TYGQCPYEGM TNHETLQQIM RGYRLPRPAA CPAEVYVLML ECWRSSPEER PSFATLREKL
     HAIHRCHP
//
